Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Revenue	$ 3,658	$ 3,658
Operating expenses:
General and administrative (including stock-based compensation (Note 9))	1,816,341	2,375,145
Depreciation	293,577	623,934
Impairment loss on property and equipment	1,684,562	1,750,000
Research and development (including stock-based compensation (Note 9))	348,559	520,462
Total operating expenses	4,143,039	5,269,541
Loss from operations	(4,139,381)	(5,265,883)
Other expense:
Interest expense, net	382,686	375,705
Total other expense	380,686	373,705
Net loss	(4,522,067)	(5,641,588)
Net loss attributable to the noncontrolling interest	3,634	11,397
Net loss attributable to Bion	(4,518,433)	(5,630,191)
Conversion inducement		(9,593)
Net loss applicable to Bion's common stockholders	$ (4,518,433)	$ (5,639,784)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in dollars per share)	$ (0.20)	$ (0.27)
Weighted-average number of common shares outstanding:
Basic and diluted (in shares)	22,745,281	20,545,456